Public Calendar: September 29 - October 5, 2024
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 09/30/2024
Location: Silver Spring, MD
Subject: Meeting with the Brazilian Health Regulatory Authority and Signing of Expanded Confidentiality Commitment
FDA Participant/Group: Several FDA staff participated
Non FDA Participant/Group: Antonio Barra Torres, Augusto Geyer, Karin Schuck Hemesath Mendes, Samia Rocha de Oliveira melo (Brazilian Health Regulatory Authority);
Event Date: 10/04/2024
Location: Washington, DC
Subject: The University of Texas System Chancellor's Council Executive Committee Fall Meeting - From Research to Remedy: How Drugs are Developed and Approved
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other invited attendees
Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner
No Significant Event
Official Name: Jim Jones, Deputy Commissioner for Human Foods
No Significant Event
Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 10/01/2024
Location: Virtual
Subject: National Academies' Committee Meeting on Strategies to Better Align Investments in Innovations for Therapeutic Development with Disease Burden and Unmet Needs
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Academies of Sciences, Engineering, and Medicine (NASEM)
Event Date: 10/02/2024
Location: Virtual
Subject: Drug Shortages
FDA Participant/Group: KELLY NGAN; JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Several representatives from Baxter
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 09/30/2024
Location: Silver Spring, MD
Subject: National Institute for Innovation in Manufacturing Biopharmaceuticals Active Listening Meeting - Industrywide Survey on Adoption of Rapid Methods to Detect Microbial Contamination; Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and federal stakeholders
Event Date: 09/30/2024
Location: Virtual
Subject: The Organisation for Professionals in Regulatory Affairs (TOPRA) Symposium 2024; Fireside Chat: Regulation and Innovation - Keeping Up with the Times
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academic, research, and regulatory stakeholders
Event Date: 10/01/2024
Location: Virtual
Subject: Duke-Margolis Institute for Health Policy Virtual Roundtable on Gene Therapy Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Health policy, public health, research, and government stakeholders
Event Date: 10/01/2024
Location: Virtual
Subject: FDA - Alliance for Regenerative Medicine Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the Alliance for Regenerative Medicine
Event Date: 10/02/2024
Location: Aurora, CO
Subject: 2024 American Association of Tissue Banks Annual Meeting; Speaker: FDA Updates on HCT/Ps (Human Cells, Tissues, or Cellular or Tissue-Based Products)
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academic, and healthcare stakeholders
Event Date: 10/02/2024
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Workshop on Mpox; Speaker: Mpox Vaccines Available in the United States
FDA Participant/Group: DAVID KASLOW;
Non FDA Participant/Group: Industry and regulatory stakeholders
Official Name: Michelle Tarver, M.D., Ph.D., Acting Director, Center for Devices and Radiological Health
Event Date: 10/03/2024
Location: Silver Spring, MD
Subject: Medical Technology Innovation Priorities
FDA Participant/Group: MARK TRUMBORE; SHUMAYA ALI; OWEN FARIS; MARIEANN BRILL; RAQUEL PEAT; TROY TAZBAZ; BINITA ASHAR; LAURENCE COYNE; MATTHEW DIAMOND; ROSS SEGAN; ANGELA KRUEGER; JULIE MORABITO;
Non FDA Participant/Group: Diane Johnson, Joy Sacmar, Julia Hwang, Karen Mahoney, Patrick Courtis, Peter Schulam, Raina Dauria, Shan Jegatheeswaran, Stacey Bentley (Johnson and Johnson);
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 09/30/2024
Location: Orlando, FL
Subject: American Academy of Pediatrics (AAP) National Conference and Exhibition; Speaker: What’s All the Buzz? New and Emerging Nicotine Products Addicting Youth
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the American Academy of Pediatrics (AAP) and registered attendees
Event Date: 10/01/2024
Location: Charlotte, NC
Subject: Health Professionals Advancing LGBTQ+ Equality (GLMA) 42nd Annual Conference On LGBTQ+ Health; Speaker: Smoking Out Corporate Tobacco’s Influence on Queer Health
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from Health Professionals Advancing LGBTQ+ Equality (GLMA) and registered attendees
Event Date: 10/03/2024
Location: Virtual
Subject: Altria Stakeholder Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Altria
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
Event Date: 09/30/2024
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: TIMOTHY SCHELL; CINDY BURNSTEEL;
Non FDA Participant/Group: Bill Bookout, Todd Harrison (National Animal Supplement Council (NASC));
Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event